Evidence map›Paper›PMID 24297168›Full record

ArticleThe Journal of biological chemistry2014

ADP-dependent conformational changes distinguish Mycobacterium tuberculosis SecA2 from SecA1.

Nadia G D'Lima, Carolyn M Teschke

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. SecA: a potential antimicrobial target.Future medicinal chemistry · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nadia G D'LimaFrom the Departments of Molecular and Cell Biology and.
Carolyn M Teschke
University of Connecticut · US

Funding

Function of SecA2 in Mycobacterium tuberculosis protein exportR03AI072065 · NIAID · UNIVERSITY OF CONNECTICUT STORRS · PI TESCHKE, CAROLYN M · 2007 to 2008
$151k
NIAID NIH HHS R03 AI072065
6 · The paper itself

Abstract

In bacteria, most secreted proteins are exported through the SecYEG translocon by the SecA ATPase motor via the general secretion or "Sec" pathway. The identification of an additional SecA protein, particularly in Gram-positive pathogens, has raised important questions about the role of SecA2 in both protein export and establishment of virulence. We previously showed in Mycobacterium tuberculosis, the causative agent of tuberculosis, the accessory SecA2 protein possesses ATPase activity that is required for bacterial survival in host macrophages, highlighting its importance in virulence. Here, we show that SecA2 binds ADP with much higher affinity than SecA1 and releases the nucleotide more slowly. Nucleotide binding also regulates movement of the precursor-binding domain in SecA2, unlike in SecA1 or conventional SecA proteins. This conformational change involving closure of the clamp in SecA2 may provide a mechanism for the cell to direct protein export through the conventional SecA1 pathway under normal growth conditions while preventing ordinary precursor proteins from interacting with the specialized SecA2 ATPase.

Indexed as

Adenosine DiphosphateAdenosine TriphosphatasesAnimalsBacterial ProteinsHumansMacrophagesMembrane Transport ProteinsMycobacterium tuberculosisProtein BindingProtein Structure, TertiaryProtein TransportAdenosine DiphosphateAdenosine TriphosphatasesBacterial ProteinsMembrane Transport ProteinsSecA1 protein, Mycobacterium tuberculosisSecA2 protein, MycobacteriumATPasesFRETProtein ExportSecretionTuberculosis

Identifiers

PMID24297168
PMCPMC3900974
OpenAlexW2069897942

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.